Childhood all blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice

被引:43
作者
Borgmann, A
Baldy, C
Von Stackelberg, A
Beyermann, B
Fichtner, I
Nürnberg, P
Henze, G
机构
[1] Dept Pediat Oncol Hematol, Charite, Berlin, Germany
[2] Max Delbruck Ctr Mol Med, Berlin, Germany
[3] Inst Med Genet, Charite, Berlin, Germany
关键词
acute lymphoblastic leukemia; graft versus leukemia effect; NOD/SCID mice; SCID mice xenotransplantation;
D O I
10.1080/08880010050211349
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
For children with an early bone marrow relapse or relapsed T-cell acute lymphoblastic leukemia (ALL), allogeneic bone marrow transplantation (BMT) is currently the only therapeutic option with a curative approach. Here, the graft versus leukemia (GvL) effect seems to play an important role for long-term immunological control of leukemia. If a bone marrow donor is not available, autologous stem cell transplantation after high-dose chemotherapy has been used as an alternative option. The objective of this work was the induction of tumor specific cytotoxic T-lymphocytes (CTL) against autologous leukemia cells in order to generate the missing GvL effect after autoBMT. The first step was the establishment of an optimized and reliable mouse model. The second step was the induction of a GvL effect in an allogeneic approach to serve as a basis for further GvL experiments in an autologous approach in this mouse model. Leukemia cells from 11 out of 16 different pediatric patients were successfully established in mice and in one case passaged over 19 generations without changes of genotype or phenotype. The antileukemic activity of allogenic human MNC as a GvL reaction and an accompanying GvHD in the mouse model was shown. Xenotransplanted ALL can be considered a clinically relevant model mimicking the human conditions and as a useful preclinical tool for the evaluation of novel immuno- or genetherapeutic approaches.
引用
收藏
页码:635 / 650
页数:16
相关论文
共 21 条
[1]   Good engraftment of B-cell precursor ALL in NOD-SCID mice [J].
Baersch, G ;
Mollers, T ;
Hotte, A ;
DockhornDworniczak, B ;
Rube, C ;
Ritter, J ;
Jurgens, H ;
Vormoor, J .
KLINISCHE PADIATRIE, 1997, 209 (04) :178-185
[2]   Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia; A matched-pair analysis [J].
Beyermann, B ;
Adams, HP ;
Henze, G .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2231-2237
[3]   COMPLETE SUBTYPING OF THE HLA-A LOCUS BY SEQUENCE-SPECIFIC AMPLIFICATION FOLLOWED BY DIRECT SEQUENCING OR SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS [J].
BLASCZYK, R ;
HAHN, U ;
WEHLING, J ;
HUHN, D ;
SALAMA, A .
TISSUE ANTIGENS, 1995, 46 (02) :86-95
[4]   GENERAL METHOD FOR ISOLATION OF HIGH MOLECULAR-WEIGHT DNA FROM EUKARYOTES [J].
BLIN, N ;
STAFFORD, DW .
NUCLEIC ACIDS RESEARCH, 1976, 3 (09) :2303-2308
[5]   AUTOLOGOUS BONE-MARROW TRANSPLANTS COMPARED WITH CHEMOTHERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN A 2ND REMISSION - A MATCHED-PAIR ANALYSIS [J].
BORGMANN, A ;
SCHMID, H ;
HARTMANN, R ;
BAUMGARTEN, E ;
HERMANN, K ;
KLINGEBIEL, T ;
EBELL, W ;
ZINTL, F ;
GADNER, H ;
HENZE, G .
LANCET, 1995, 346 (8979) :873-876
[6]   A SEVERE COMBINED IMMUNODEFICIENCY MUTATION IN THE MOUSE [J].
BOSMA, GC ;
CUSTER, RP ;
BOSMA, MJ .
NATURE, 1983, 301 (5900) :527-530
[7]  
Hampe J., 1992, Human Antibodies and Hybridomas, V3, P186
[8]  
Hartmann R, 1994, HAEMATOL BLOOD TRANS, V36, P374
[9]  
HENZE G, 1991, BLOOD, V78, P1166
[10]   Immunotherapy of acute lymphoblastic leukemia by vaccination with autologous leukemic cells transfected with a cDNA expression plasmid coding for an allogeneic HLA class I antigen combined with interleukin-2 treatment [J].
Henze, G ;
Borgmann, A ;
von Stackelberg, A ;
Baumgarten, E ;
Uchanska-Ziegler, B ;
Ziegler, A ;
Wittig, B .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (3-4) :215-221